PTPN22 and systemic lupus erythematosus: ,69 By contrast, expression of PTPN22 R620W reduces the risk of developing Crohn’s disease70 whilst expression of a loss-of-function variant PTPN22 R263Q is associated with a reduced risk of developing RA and SLE.71